GLP-1s vs AI Economy

Panel compares GLP-1 drug revenues to AI lab valuations and discusses longevity drugs' economic impact.

Play episode from 01:05:27

chevron_right

Transcript

chevron_right

Transcript

Episode notes

This episode features a dynamic panel discussion on exponential technologies, AI advancements, robotics, and the future of humanity. Experts explore the implications of AI, robotics, biotech, and societal shifts, offering insights into what the next decade holds for innovation and civilization.

Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends

Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360

Steven Kotler is a New York Times bestselling author, and founder of the Flow Research Collective and Flow Institute, known for his work on flow and human performance.

Salim Ismail is the founder of OpenExO

Dave Blundin is the founder & GP of Link Ventures

Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified

–

My companies:

Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding

Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy

Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter

Connect with Peter:

Connect with Steven

Connect with Dave: